"HEMATOLOGY/ONCOLOGY OFFICE"

During the past decade, Orion Cancer Care conducted 119 clinical trials. In the 10-year time frame, 119 clinical trials started and 37 clinical trials were completed, i.e. on average, 31.1% percent of trials that started reached the finish line to date. In the past 5 years, 50 clinical trials started and 36 clinical trials were completed. i.e. 72% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Orion Cancer Care" #1 sponsor was "National Cancer Institute (NCI)" with 61 trials, followed by "SWOG Cancer Research Network" with 25 trials sponsored, "Alliance for Clinical Trials in Oncology" with 23 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "NRG Oncology" with 16 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Orion Cancer Care" #1 collaborator was "National Cancer Institute (NCI)" with 74 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Astellas Pharma US, Inc." with 2 trials as a collaborator and "Biologics, Inc." with 2 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Orion Cancer Care" are "Stage IV Lung Cancer AJCC v8" (8 trials), "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Recurrent Lung Non-Small Cell Carcinoma" (6 trials), "Recurrent Ovarian Carcinoma" (6 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials). Many other conditions were trialed in "Orion Cancer Care" in a lesser frequency.

Most popular intervention types in "Orion Cancer Care" are "Drug" (113 trials), "Other" (77 trials), "Biological" (54 trials), "Procedure" (38 trials) and "Radiation" (13 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (33 trials), "Quality-of-Life Assessment" (32 trials), "Computed Tomography" (23 trials), "Biospecimen Collection" (21 trials) and "Questionnaire Administration" (21 trials). Other intervention names were less common.

The vast majority of trials in "Orion Cancer Care" are 113 trials for "All" genders, 16 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Orion Cancer Care". undefined are not yet recruiting, 49 are recruiting, 64 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Orion Cancer Care, 3 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Orion Cancer Care, 2 "Phase 1" clinical trials were conducted, 72 "Phase 2" clinical trials and 66 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".